5WDY: Crystal Structure Of Wnk1 In Complex With 1-Cyclohexyl-N-({6 [2-(3-Methoxyphenyl)Pyridin-4-Yl]-1h-Indol-3-Yl}Methyl)Meth (Compound 6)
reference: Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models., Yamada K, Levell J, Yoon T, Kohls D, Yowe D, Rigel DF, Imase H, Yuan J, Yasoshima K, DiPetrillo K, Monovich L, Xu L, Zhu M, Kato M, Jain M, Idamakanti N, Taslimi P, Kawanami T, Argikar UA, Kunjathoor V, Xie X, Yagi YI, Iwaki Y, Robinson Z, Park HM, J Med Chem. 2017 Aug 3. doi: 10.1021/acs.jmedchem.7b00708. PMID: 28771350

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).